Status:

COMPLETED

Modified Cervical Inversion During CS in Placenta Previa

Lead Sponsor:

Aljazeera Hospital

Collaborating Sponsors:

Suez Canal University

Conditions:

Placenta Previa

Eligibility:

FEMALE

22-40 years

Phase:

NA

Brief Summary

There is an increasing rates of placenta previa nowadays

Detailed Description

several techniques were described to control bleeding .

Eligibility Criteria

Inclusion

  • pregnant women 38 weeks or more with placenta previa

Exclusion

  • pregnant ladies with normally implanted placenta or placenta accreat , increta or percreta

Key Trial Info

Start Date :

January 10 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 15 2019

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT03772184

Start Date

January 10 2019

End Date

May 15 2019

Last Update

February 22 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Algazeerah and helwan university

Giza, Egypt